INBX

Inhibrx Biosciences Stock Analysis

AI Rating

Low
  • Quality5/10
  • Growth↑ 6/10
  • Value↓ 0/10
Inhibrx Biosciences sales and earnings growth
INBX Growth
Good
  • Revenue Y/Y↑ 550.00%
  • EPS Y/Y↓ -107.93%
  • FCF Y/Y↑ 34.10%
Inhibrx Biosciences gross and profit margin trends
INBX Profitability
Neutral
  • Gross margin ↑ 100.00%
  • EPS margin↓ -10773.50%
  • ROIC 5Y↓ 0.00%
Inhibrx Biosciences net debt vs free cash flow
INBX Risk
Great
  • Debt / Equity↑ 13.4
  • Debt / FCF↓ 0.0
  • Interest coverage↓ -10.5

Inhibrx Biosciences stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

More Biotechnology stocks ↗